*Merck Frosst Canada Ltd. and Schering-Plough Canada Inc. are integrating their operations to form a new organization called Merck. Merck is a global health care leader with a diversified portfolio of prescription medicines, vaccines, consumer and animal health products. In Canada, Merck markets over 530 pharmaceutical, consumer and animal health products and is a leader in a broad range of areas such as cardiology, immunology, infectious diseases, respiratory, vaccines, women's health and sun care, and is focused on expanding offerings in other areas, including virology, oncology and diabetes. Merck is one of the top 25 R&D investors in Canada, with an investment of $121 million in 2008 and has one of the largest biomedical research facilities in Canada with the mandate to discover new therapies for the treatment of infectious diseases. Merck also has a large manufacturing facility in Quebec dedicated to the annual production of some 35 million units including the Claritin and Aerius brands. Based in Montréal, Quebec, Merck employs over 1800 people across Canada. For more information about our operations in Canada visit www.merckfrosst.com or www.schering-plough.ca.
Carlos Dourado, PRESIDENT
Adresse :
16711 TransCanada Highway
Kirkland, QC H9H 3L1
Canada
Numéro de téléphone :
514-428-7920
MERCK FROSST CANADA LTD. ne possède aucune filiale qui pourrait être directement intéressée au résultat de l'engagement